In focus · trending topic

Abuse Deterrent

5 stories · following the connections

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin®

By Nasdaq OMXJan 17, 2017, 1:00 PM UTC